CCHT Recertification Anderson Continuing Education (CE) Practice Test

Lifelong immunosuppression therapy is a standard follow-up care requirement for kidney transplant patients because their immune systems need to be suppressed to prevent rejection of the transplanted organ. After receiving a kidney transplant, the body can recognize the new kidney as foreign and launch an immune response against it. To counteract this rejection risk, patients must take immunosuppressive medications for the rest of their lives.

These medications help to inhibit the immune response while allowing the body to accept the new organ. Regular monitoring and adjustments to the medication regimen are typically necessary to balance the risk of rejection with the potential for side effects from immunosuppression. This therapy is a foundational aspect of post-transplant care, emphasizing the importance of adherence to medication schedules and regular follow-up appointments with healthcare providers.